000			02098 a2200601 4500
005			20250518015518.0
264		0	_c20190507
008			201905s 0 0 eng d
022			_a1745-6215
024	7		_a10.1186/s13063-018-3115-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aChen, Yiyi
245	0	0	_aIntravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study. _h[electronic resource]
260			_bTrials _cJan 2019
300			_a34 p. _bdigital
500			_aPublication Type: Clinical Trial Protocol; Journal Article
650	0	4	_aAdenosine Triphosphate _xadministration & dosage
650	0	4	_aAdministration, Intravenous
650	0	4	_aAdministration, Oral
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAffect _xdrug effects
650	0	4	_aAged
650	0	4	_aAntidepressive Agents, Second-Generation _xadministration & dosage
650	0	4	_aChina
650	0	4	_aDepressive Disorder, Major _xdiagnosis
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFeasibility Studies
650	0	4	_aFemale
650	0	4	_aFluoxetine _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPatient Health Questionnaire
650	0	4	_aPhosphocreatine _xadministration & dosage
650	0	4	_aPilot Projects
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aSelective Serotonin Reuptake Inhibitors _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aCao, Xiaomin
700	1		_aZang, Wensi
700	1		_aTan, Shanyong
700	1		_aOu, Chun-Quan
700	1		_aShen, Xiaoyan
700	1		_aGao, Tianming
700	1		_aZhao, Lianxu
773	0		_tTrials _gvol. 20 _gno. 1 _gp. 34
856	4	0	_uhttps://doi.org/10.1186/s13063-018-3115-4 _zAvailable from publisher's website
999			_c29237816 _d29237816